Ecnoglutide, a once-weekly GLP-1 receptor agonist, showed up to 13.2% weight loss over 40 weeks in obese or overweight adults without diabetes in a Phase III...
New research suggests that regular cannabis use may be linked to a lower risk of obesity, with daily users being 32% less likely to be obese....